{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:42:48Z","timestamp":1792222968584,"version":"4.4.0"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004493","name":"International Atomic Energy Agency","doi-asserted-by":"publisher","award":["25076"],"award-info":[{"award-number":["25076"]}],"id":[{"id":"10.13039\/501100004493","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21977037"],"award-info":[{"award-number":["21977037"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22377035"],"award-info":[{"award-number":["22377035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.micpath.2026.108663","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T06:50:49Z","timestamp":1782543049000},"page":"108663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Repurposing Evacetrapib as a membrane disruption agent inducing rapid autolysis in MRSA"],"prefix":"10.1016","volume":"221","author":[{"given":"Dan","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuye","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Yu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3436-3091","authenticated-orcid":false,"given":"Ruiguang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5425-321X","authenticated-orcid":false,"given":"Xuesong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2026.108663_bib1","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S1473-3099(16)30323-1","article-title":"Potential of marine natural products against drug-resistant fungal, viral, and parasitic infections","author":"Abdelmohsen","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108663_bib2","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.biopha.2017.08.006","article-title":"Drug-resistant gram-negative uropathogens: a review","author":"Khoshnood","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.micpath.2026.108663_bib3","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2026.108663_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.mib.2023.102334","article-title":"Counteracting antibiotic resistance enzymes and efflux pumps","author":"Zheng","year":"2023","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.micpath.2026.108663_bib5","article-title":"The global prevalence of Daptomycin, Tigecycline, Quinupristin\/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase-negative staphylococci strains: a systematic review and meta-analysis","volume":"56","author":"Shariati","year":"2020","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"10.1016\/j.micpath.2026.108663_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.GPP3-0057-2018","article-title":"Antibiotic resistance and the MRSA problem","author":"Vestergaard","year":"2019","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.micpath.2026.108663_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jare.2019.10.005","article-title":"Vancomycin resistant Staphylococcus aureus infections: a review of case updating and clinical features","author":"Cong","year":"2020","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.micpath.2026.108663_bib8","article-title":"Prevalence and therapies of antibiotic-resistance in Staphylococcus aureus","volume":"107","author":"Guo","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2026.108663_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf4268","article-title":"Mechanisms of bacterial persistence during stress and antibiotic exposure","author":"Harms","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.micpath.2026.108663_bib10","article-title":"Membrane-Active metallopolymers: repurposing and rehabilitating antibiotics to gram-negative superbugs","author":"Hwang","year":"2023","journal-title":"Adv. Healthcare Mater."},{"key":"10.1016\/j.micpath.2026.108663_bib11","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2217\/fmb-2015-0015","article-title":"Membrane-targeting AM-0016 kills mycobacterial persisters and shows low propensity for resistance development","author":"Mukherjee","year":"2016","journal-title":"Future Microbiol."},{"key":"10.1016\/j.micpath.2026.108663_bib12","doi-asserted-by":"crossref","first-page":"21292","DOI":"10.1021\/acsami.9b20161","article-title":"Small molecules with membrane-active antibacterial activity","author":"Zhou","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.micpath.2026.108663_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrmicro.2017.42","article-title":"Persistent bacterial infections and persister cells","author":"Fisher","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2026.108663_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/femsre\/fuab042","article-title":"Phenotypic heterogeneity in persisters: a novel 'hunker' theory of persistence","author":"Urbaniec","year":"2022","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.micpath.2026.108663_bib15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/femsre\/fux001","article-title":"Formation, physiology, ecology, evolution and clinical importance of bacterial persisters","author":"Van den Bergh","year":"2017","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.micpath.2026.108663_bib16","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202051034","article-title":"Antibiotic resistance and persistence-Implications for human health and treatment perspectives","author":"Huemer","year":"2020","journal-title":"EMBO Rep."},{"key":"10.1016\/j.micpath.2026.108663_bib17","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1194\/jlr.M018069","article-title":"Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure","author":"Cao","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.micpath.2026.108663_bib18","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1194\/jlr.R027011","article-title":"New molecular insights into CETP structure and function: a review","author":"Charles","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.micpath.2026.108663_bib19","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","article-title":"Evacetrapib and cardiovascular outcomes in high-risk vascular disease","author":"Lincoff","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micpath.2026.108663_bib20","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","author":"Schwartz","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micpath.2026.108663_bib21","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.amjcard.2014.03.045","article-title":"Efficacy, safety, tolerability, and pharmacokinetic profile of evacetrapib administered as monotherapy or in combination with atorvastatin in Japanese patients with dyslipidemia","author":"Teramoto","year":"2014","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.micpath.2026.108663_bib22","article-title":"High-affinity SOAT1 ligands remodeled cholesterol metabolism program to inhibit tumor growth","volume":"292","author":"Wang","year":"2022","journal-title":"BMC Med."},{"key":"10.1016\/j.micpath.2026.108663_bib23","series-title":"Performance Standards for Antimicrobial Susceptibility Testing","year":"2024"},{"key":"10.1016\/j.micpath.2026.108663_bib24","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/jac\/dkae051","article-title":"Repurposing cinacalcet suppresses multidrug-resistant Staphylococcus aureus by disruption of cell membrane and inhibits biofilm by targeting IcaR","author":"Fang","year":"2024","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2026.108663_bib25","article-title":"Crizotinib shows antibacterial activity against gram-positive bacteria by reducing ATP production and targeting the CTP synthase PyrG","author":"Zheng","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.micpath.2026.108663_bib26","article-title":"EttA is likely non-essential in Staphylococcus aureus persistence, fitness or resistance to antibiotics","volume":"288","author":"Meir","year":"2020","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.micpath.2026.108663_bib27","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1080\/21505594.2020.1770493","article-title":"Insights into idarubicin antimicrobial activity against methicillin-resistant Staphylococcus aureus","author":"She","year":"2020","journal-title":"Virulence"},{"key":"10.1016\/j.micpath.2026.108663_bib28","doi-asserted-by":"crossref","first-page":"16529","DOI":"10.1073\/pnas.1904700116","article-title":"A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus","author":"Kim","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.micpath.2026.108663_bib29","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1093\/jac\/dkaf190","article-title":"Oleanolic acid derivative bardoxolone combats multidrug-resistant Staphylococcus aureus by destroying cell membrane and pyruvate metabolism pathway","author":"Zheng","year":"2025","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2026.108663_bib30","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032914","article-title":"Optimization of the hemolysis assay for the assessment of cytotoxicity","author":"S\u00e6b\u00f8","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.micpath.2026.108663_bib31","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.7150\/ijbs.60894","article-title":"CD147 confers temozolomide resistance of glioma cells via the regulation of \u03b2-TrCP\/Nrf2 pathway","author":"Bu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.micpath.2026.108663_bib32","first-page":"272","article-title":"Felodipine enhances aminoglycosides efficacy against implant infections caused by methicillin-resistant Staphylococcus aureus, persisters and biofilms","author":"Zhang","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.micpath.2026.108663_bib33","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1128\/AAC.48.5.1461-1468.2004","article-title":"Analysis of the effects of chlorhexidine on oral biofilm vitality and structure based on viability profiling and an indicator of membrane integrity","author":"Hope","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.micpath.2026.108663_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2020.103721","article-title":"A protocol for studying structural dynamics of proteins by quantitative crosslinking mass spectrometry and data-independent acquisition","author":"M\u00fcller","year":"2020","journal-title":"J. Proteonomics"},{"key":"10.1016\/j.micpath.2026.108663_bib35","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1128\/jcm.19.5.680-686.1984","article-title":"Methodological aspects of Staphylococcus aureus peptidoglycan serology: comparisons between solid-phase radioimmunoassay and enzyme-linked immunosorbent assay","author":"Christensson","year":"1984","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.micpath.2026.108663_bib36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.aca.2015.07.049","article-title":"An immunochemical strategy based on peptidoglycan synthetic peptide epitopes to diagnose Staphylococcus aureus infections","author":"Pastells","year":"2015","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.micpath.2026.108663_bib37","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1021\/bi9826299","article-title":"Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli","author":"Wu","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.micpath.2026.108663_bib38","article-title":"Antibacterial activity and mechanisms of D-3263 against Staphylococcus aureus","volume":"224","author":"Liu","year":"2024","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.micpath.2026.108663_bib39","doi-asserted-by":"crossref","first-page":"5915","DOI":"10.2147\/IJN.S138185","article-title":"Photodynamic antimicrobial chemotherapy for Staphylococcus aureus and multidrug-resistant bacterial burn infection in vitro and in vivo","author":"Mai","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.micpath.2026.108663_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.micpath.2026.108663_bib41","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1021\/ci300505n","article-title":"CHARMM-GUI ligand binder for absolute binding free energy calculations and its application","author":"Jo","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.micpath.2026.108663_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000880","article-title":"Automated builder and database of protein\/membrane complexes for molecular dynamics simulations","author":"Jo","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2026.108663_bib43","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bpj.2009.04.013","article-title":"CHARMM-GUI membrane builder for mixed bilayers and its application to yeast membranes","author":"Jo","year":"2009","journal-title":"Biophys. J."},{"key":"10.1016\/j.micpath.2026.108663_bib44","doi-asserted-by":"crossref","DOI":"10.1063\/5.0018516","article-title":"Heterogeneous parallelization and acceleration of molecular dynamics simulations in GROMACS","author":"P\u00e1ll","year":"2020","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.micpath.2026.108663_bib45","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/jcc.23702","article-title":"CHARMM-GUI membrane builder toward realistic biological membrane simulations","author":"Wu","year":"2014","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.micpath.2026.108663_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/membranes13030304","article-title":"Cardiolipin strongly inhibits the leakage activity of the short antimicrobial peptide ATRA-1 in comparison to LL-37, in model membranes mimicking the lipid composition of Staphylococcus aureus","author":"Calder\u00f3n-Rivera","year":"2023","journal-title":"Membranes"},{"key":"10.1016\/j.micpath.2026.108663_bib47","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bpc.2018.04.001","article-title":"Biophysical evaluation of cardiolipin content as a regulator of the membrane lytic effect of antimicrobial peptides","author":"Hern\u00e1ndez-Villa","year":"2018","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.micpath.2026.108663_bib48","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00339-20","article-title":"Lipidomic and ultrastructural characterization of the cell envelope of Staphylococcus aureus grown in the presence of human serum","author":"Hines","year":"2020","journal-title":"mSphere"},{"key":"10.1016\/j.micpath.2026.108663_bib49","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1128\/JB.00288-11","article-title":"Characterization of Staphylococcus aureus cardiolipin synthases 1 and 2 and their contribution to accumulation of cardiolipin in stationary phase and within phagocytes","author":"Koprivnjak","year":"2011","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2026.108663_bib50","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nsmb1197","article-title":"Crystal structure of cholesteryl ester transfer protein reveals a long tunnel and four bound lipid molecules","author":"Qiu","year":"2007","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.micpath.2026.108663_bib51","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools 4: automated docking with selective receptor flexibility","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.micpath.2026.108663_bib52","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.micpath.2026.108663_bib53","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/prot.340220308","article-title":"Size-independent comparison of protein three-dimensional structures","author":"Maiorov","year":"1995","journal-title":"Proteins"},{"key":"10.1016\/j.micpath.2026.108663_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1012837","article-title":"Mdciao: accessible analysis and visualization of molecular dynamics simulation data","author":"P\u00e9rez-Hern\u00e1ndez","year":"2025","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.micpath.2026.108663_bib55","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/0022-2836(92)91058-W","article-title":"Hydrogen bonding in globular proteins","author":"Stickle","year":"1992","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.micpath.2026.108663_bib56","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1021\/jm3014635","article-title":"Attenuating Staphylococcus aureus virulence gene regulation: a medicinal chemistry perspective","author":"Gordon","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.micpath.2026.108663_bib57","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1128\/JB.186.16.5267-5280.2004","article-title":"Identification of sarV (SA2062), a new transcriptional regulator, is repressed by SarA and MgrA (SA0641) and involved in the regulation of autolysis in Staphylococcus aureus","author":"Manna","year":"2004","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2026.108663_bib58","doi-asserted-by":"crossref","first-page":"7573","DOI":"10.1128\/JB.01048-07","article-title":"Perturbation of cell wall synthesis suppresses autolysis in staphylococcus aureus: evidence for coregulation of cell wall synthetic and hydrolytic enzymes","author":"Antignac","year":"2007","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.micpath.2026.108663_bib59","article-title":"Staphylococcus aureus sacculus mediates activities of M23 hydrolases","volume":"6706","author":"Razew","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108663_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1036964","article-title":"One fold, many functions-M23 family of peptidoglycan hydrolases","author":"Razew","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108663_bib61","article-title":"Transcriptomic analysis of Staphylococcus aureus under the stress condition caused by Litsea cubeba L. essential oil via RNA sequencing","volume":"1693","author":"Yang","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108663_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.1006765","article-title":"Staphylococcus aureus lipoproteins in infectious diseases","author":"Mohammad","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108663_bib63","article-title":"Evaluation of Staphylococcus aureus lipoproteins: role in nutritional acquisition and pathogenicity","volume":"1404","author":"Shahmirzadi","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2026.108663_bib64","doi-asserted-by":"crossref","first-page":"32593","DOI":"10.1074\/jbc.M111.258863","article-title":"LytN, a murein hydrolase in the cross-wall compartment of Staphylococcus aureus, is involved in proper bacterial growth and envelope assembly","author":"Frankel","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2026.108663_bib65","first-page":"E2100","article-title":"Antibiotics induce redox-related physiological alterations as part of their lethality","author":"Dwyer","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.micpath.2026.108663_bib66","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.cell.2007.06.049","article-title":"A common mechanism of cellular death induced by bactericidal antibiotics","author":"Kohanski","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.micpath.2026.108663_bib67","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1126\/science.284.5419.1523","article-title":"Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen","author":"McKenney","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.micpath.2026.108663_bib68","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","article-title":"Bacterial biofilms: a common cause of persistent infections","author":"Costerton","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.micpath.2026.108663_bib69","article-title":"Intracellular Staphylococcus aureus persisters upon antibiotic exposure","volume":"2200","author":"Peyrusson","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108663_bib70","doi-asserted-by":"crossref","first-page":"777","DOI":"10.14348\/molcells.2014.0265","article-title":"Cholesteryl ester transfer protein (CETP) deficiency and CETP inhibitors","author":"Mabuchi","year":"2014","journal-title":"Mol. Cells"},{"key":"10.1016\/j.micpath.2026.108663_bib71","author":"Information"},{"key":"10.1016\/j.micpath.2026.108663_bib72","doi-asserted-by":"crossref","first-page":"D1265","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank knowledgebase for 2024","author":"Knox","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.micpath.2026.108663_bib73","article-title":"Novel antibiotics from bacterial blueprints","volume":"492","author":"Willson","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.micpath.2026.108663_bib74","article-title":"Ca(2+)-Daptomycin targets cell wall biosynthesis by forming a tripartite complex with undecaprenyl-coupled intermediates and membrane lipids","volume":"1455","author":"Grein","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micpath.2026.108663_bib75","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cell.2020.02.056","article-title":"The science of antibiotic discovery","author":"Lewis","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.micpath.2026.108663_bib76","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nature14098","article-title":"A new antibiotic kills pathogens without detectable resistance","author":"Ling","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.micpath.2026.108663_bib77","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1021\/es103450g","article-title":"Diffusion of nanoparticles in a biofilm","author":"Peulen","year":"2011","journal-title":"Environ. Sci. Technol."},{"key":"10.1016\/j.micpath.2026.108663_bib78","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc9917","article-title":"A polymeric approach toward resistance-resistant antimicrobial agent with dual-selective mechanisms of action","author":"Bai","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.micpath.2026.108663_bib79","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.drup.2018.03.002","article-title":"Fighting bacterial persistence: current and emerging anti-persister strategies and therapeutics","author":"Defraine","year":"2018","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.micpath.2026.108663_bib80","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.tim.2014.03.008","article-title":"Bacterial persisters: formation, eradication, and experimental systems","author":"Helaine","year":"2014","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.micpath.2026.108663_bib81","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/jphp.12287","article-title":"Effects of the cholesteryl ester transfer protein inhibitor evacetrapib on lipoproteins, apolipoproteins and 24-h ambulatory blood pressure in healthy adults","author":"Suico","year":"2014","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.micpath.2026.108663_bib82","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1096\/fj.14-269043","article-title":"Translating dosages from animal models to human clinical trials--revisiting body surface area scaling","author":"Blanchard","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.micpath.2026.108663_bib83","first-page":"2099","article-title":"Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial","author":"Nicholls","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.micpath.2026.108663_bib84","doi-asserted-by":"crossref","first-page":"8254","DOI":"10.1021\/acs.jpcb.6b01928","article-title":"Mechanism of inhibition of cholesteryl ester transfer protein by small molecule inhibitors","author":"Chirasani","year":"2016","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.micpath.2026.108663_bib85","doi-asserted-by":"crossref","first-page":"37321","DOI":"10.1074\/jbc.M112.380063","article-title":"Crystal structures of cholesteryl ester transfer protein in complex with inhibitors","author":"Liu","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2026.108663_bib86","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.atherosclerosis.2017.01.011","article-title":"Anacetrapib, but not evacetrapib, impairs endothelial function in CETP-Transgenic mice in spite of marked HDL-C increase","author":"Simic","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.micpath.2026.108663_bib87","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gkv1145","article-title":"Update of the PRIDE database and its related tools","volume":"2015","author":"Vizca\u00edno","year":"2016","journal-title":"Nucleic Acids Res."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240102600389X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088240102600389X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:29:55Z","timestamp":1792222195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088240102600389X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":87,"alternative-id":["S088240102600389X"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108663","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing Evacetrapib as a membrane disruption agent inducing rapid autolysis in MRSA","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2026.108663","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108663"}}